Kevin loves science. He is devoted to understanding why we age and why we ultimately succumb to age-related disease. In doing so, he aims to redefine what it means to "grow old" through the discovery and development of novel therapeutics that dramatically extend human healthspan. Currently, Kevin is a graduate student in Harvard's Biological and Biomedical Sciences program. There, he seeks to develop novel protein-centric technologies as well as functionally characterize the expanding universe of microproteins.
At Apollo, Kevin focuses on commercializing therapeutics that facilitate systemic rejuvenation as well as identifying novel trends within the aging space that warrant further exploration.